JPL Wealth Management’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$16 – 2029
2026
Q2
$16 Sell
5
-28
-85% -$114 ﹤0.01% 1813
2026
Q1
$146 Buy
+33
New +$178 ﹤0.01% 1443

Other funds holding NAGE

JPL Wealth Management's NAGE Position: Q3 2026 in Review

JPL Wealth Management sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 5 shares — an estimated $16 sold.

JPL Wealth Management first reported a position in NAGE in Q1 2026 and held it in 2 quarters. The position peaked at $146 in Q1 2026. 111 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

  • JPL Wealth Management reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
  • JPL Wealth Management sold 5 Niagen Bioscience shares in Q3 2026, an estimated $16.
  • JPL Wealth Management first reported a position in Niagen Bioscience in Q1 2026 and held it in 2 quarters.
  • JPL Wealth Management's Niagen Bioscience position peaked at $146 in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.